Aurobindo Pharma arm gets USFDA nod for Azacitidine for Injection to treat myelodysplastic syndrome Ruchika Sharma4 Jan 2023 11:07 AM ISTThe product is indicated for the treatment of adult patients with the following FAB myelodysplastic syndrome (MDS) subtypes.
Hypomethylating agents Could Activate "Sleeping" Cancer-Causing Gene: NEJM Medical Dialogues Editorial Team26 May 2022 9:15 PM ISTChina: Hypomethylating agents (HMA) are currently used as a first-line treatment for patients with myelodysplastic syndrome (MDS) -and increasingly in...
USFDA lifts partial clinical hold on studies evaluating magrolimab in combination with azacitidine: Gilead Sciences Ruchika Sharma12 April 2022 4:49 PM ISTFoster City: Gilead Sciences, Inc. has recently announced that the U.S. Food and Drug Administration (USFDA) has lifted the partial clinical hold...
Anemia in the Elderly- Clinical Implications Hina Zahid14 Jun 2021 10:13 AM ISTAnaemia in elderly is a clinical challenge especially when the etiology remains uncertain and/or (multiple) comorbidities are present.Anaemia is...
PARP inhibitors increase risk of myelodysplastic syndrome and acute myeloid leukaemia: Lancet study Dr. Nandita Mohan4 Jan 2021 10:45 PM ISTInvestigators at the Normandie University, Interdisciplinary Research Unit for Cancer Prevention and Treatment, Biology and Innovative Therapeutics...
Venetoclax addition to standard treatments improves survival in myeloid blood cancers: Study Hina Zahid7 Dec 2020 8:30 AM ISTThe novel oral drug venetoclax can be safely added to standard therapies for some high-risk myeloid blood cancers and in early studies the combination...
Karnataka: Bone marrow facility inaugurated at Kasturba hospital Pooja Bhatia Bhatia18 Feb 2016 12:12 PM ISTA bone marrow transplant facility was recently inaugurated by H.S. Ballal, pro-chancellor of Manipal University at Shirdi Sai Baba Cancer Hospital and...
